Chronic hyperglycemia and subclinical myocardial injury.
about
Highlights of the year in JACC 2012High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study.Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus.Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage.Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetesObesity, subclinical myocardial injury, and incident heart failure.Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.Chronic hyperglycemia is associated with acute kidney injury in patients undergoing CABG surgery--a cohort study.Plasma Levels of High Sensitivity Cardiac Troponin T in Adults with Repaired Tetralogy of FallotInsulin resistance improves metabolic and contractile efficiency in stressed rat heart.Impact of insulin resistance on silent and ongoing myocardial damage in normal subjects: the Takahata study.Exenatide Activates the APPL1-AMPK-PPARα Axis to Prevent Diabetic Cardiomyocyte Apoptosis.Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality.The Association of Socioeconomic Status With Subclinical Myocardial Damage, Incident Cardiovascular Events, and Mortality in the ARIC Study.Variation in and prognostic importance of troponin T measured using a high-sensitivity assay in clinically stable haemodialysis patientsAssociation of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus.Acute hyperglycemia suppresses left ventricular diastolic function and inhibits autophagic flux in mice under prohypertrophic stimulationAlpha-lipoic acid improves subclinical left ventricular dysfunction in asymptomatic patients with type 1 diabetes.Universal MI definition update for cardiovascular disease.Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cellsAssociation between HbA1c levels with severity of coronary artery disease and short-term outcomes of acute ST-elevation myocardial infarction in nondiabetic patients.Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract.Prognostic impact of cardiac troponin T in patients with stable coronary artery disease and diabetes.Detection of 1,5-Anhydroglucitol by Electrochemical Impedance SpectroscopyHigh-sensitivity cardiac troponin T predicts nondipper hypertension in newly diagnosed hypertensive patients.Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease.Randomized Trial of the Effects of Insulin and Metformin on Myocardial Injury and Stress in Diabetes Mellitus: A Post Hoc Exploratory Analysis.Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy.Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt/GSK-3β signaling pathway.Relationship between high-sensitivity cardiac troponin T and the prognosis of elderly inpatients with non-acute coronary syndromes.The prognostic impact of hyperglycemia on clinical outcomes of acute heart failure: Insights from the heart function assessment registry trial in Saudi ArabiaHigh-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study
P2860
Q26865608-8B6343FE-3942-4F50-BB5D-A857C1D67E8FQ30583705-9F264139-BFAE-491F-9CED-CF51267EDBB8Q33552596-42EDF53C-48DD-4564-9A40-B1858B32AB6AQ34345083-EAD4EC0F-F159-4927-98A4-FC59EA0D9CB2Q34464759-09F461A6-46CF-4EC3-A7CA-9E38E7359C0BQ35133509-96DDD7CC-CED5-4334-8755-D9C5DEFF4A30Q35204621-44D9393A-9D2F-4127-8C80-C1C5BB685A67Q35627578-9599BE19-3F9C-4DE3-A759-BDFA62A36CB8Q36049372-91A24B3F-1201-4473-84E9-8AA47F3E424FQ36117453-472D7498-F4CB-4102-A099-0A5B1A1EA2EEQ36326775-1E1CC7CC-1B8F-444B-98C2-59D91DD0E55CQ36366910-50AAF6C9-AFFE-4987-A8B4-F05B4B0331B1Q36527607-A3E892E0-D8A7-41F4-AC90-ADCC63EAF56CQ36634511-7BB1821E-7A48-4B72-8E06-C480D1F43783Q36982063-8550AD9F-7E0C-484D-9CF5-D84D49E41942Q36996814-5BE19BE4-8510-4AFE-87AC-90ADD633D54AQ37278532-8A13D940-C7E3-43F9-8829-B4F151BA0850Q37598215-460AD2FE-47B6-431B-A830-58868D4AFF4CQ38209902-B239646A-9AE8-4416-A398-C8619EFC55E9Q39129556-55B09E2C-61F5-4DDF-A3ED-3F1925BF6335Q40937316-FAB06B30-B47C-4770-9E00-1FD3E298407FQ41578115-84B5DFEF-6CAF-4671-B3D0-95DF8222E739Q42289032-11AA6E46-B4F3-4C8F-9419-2AA2C50809F1Q42723825-AEDCB9E8-C458-457B-BE20-FA293D94CEADQ46003226-3E7A2FE6-2C60-4778-8770-40FEF37B2E24Q47101034-638ABB80-07F7-4EF3-B524-4C6D4F096459Q47669533-FA65F0D4-9E73-4FF2-A1AE-598D8DFDAFF8Q53099748-13F12267-376B-45C1-986A-E9D4EEE2E0B0Q53723158-EDDBCD80-CA49-429F-9F46-B58B2E415132Q55345404-BFCD7A63-FD90-4E16-8D23-9F54274E0444Q57142798-EFB0FF1F-3311-408F-895E-BA51854CBB6AQ57178012-D12E1BF3-203C-4633-AB5E-0364F6105C2C
P2860
Chronic hyperglycemia and subclinical myocardial injury.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Chronic hyperglycemia and subclinical myocardial injury.
@ast
Chronic hyperglycemia and subclinical myocardial injury.
@en
type
label
Chronic hyperglycemia and subclinical myocardial injury.
@ast
Chronic hyperglycemia and subclinical myocardial injury.
@en
prefLabel
Chronic hyperglycemia and subclinical myocardial injury.
@ast
Chronic hyperglycemia and subclinical myocardial injury.
@en
P2093
P2860
P1476
Chronic hyperglycemia and subclinical myocardial injury.
@en
P2093
Christie M Ballantyne
Jonathan Rubin
Kunihiro Matsushita
Ron Hoogeveen
P2860
P304
P356
10.1016/J.JACC.2011.10.875
P407
P577
2012-01-01T00:00:00Z